Alignment Healthcare trims 2026 outlook as claims pressure spreads through Medicare Advantage operations
Alignment Healthcare has cut its full-year outlook after a third quarter marked by rising medical costs, claims-processing volatility, and a sharp reversal in its quality bonus position. The company now expects about $100 million in EBITDA and $5.2 billion in revenue for the year, with membership projected to reach at least 305,000.
The downgrade lands in a year when scale has clearly expanded. Revenue reached $1.4 billion in the third quarter, up from $663.7 million in the same period a year earlier, and nine-month revenue rose to $3.9 billion from $2.9 billion. Even so, the company posted an $8 million loss in the quarter, compared with a $3.8 million profit in the prior-year period.
Margins narrowed even as the top line climbed.
The pattern points to a payer under strain from the mechanics of utilization, not from lack of enrollment momentum. In Medicare Advantage, rapid membership growth can improve scale economics, but only if medical-cost trend stays contained and claims adjudication runs cleanly. When high-acuity service lines such as catastrophic care and skilled nursing accelerate at the same time that claims administration becomes less predictable, the financial effect can be immediate.
Claims system changes fed a new round of payment disputes
CEO John Kao told investors that the headwinds include cost spikes in certain service lines and volatility in claims processing. Alignment began migrating to a comprehensive claims system last year with the goal of speeding payments, increasing automated adjudication, and strengthening payment integrity. Once the transition settled, the company found a notable rise in aggressive provider appeals and disputes in paid claims data, and those disputes added to costs.
The sequence matters because payment systems sit at the center of the payer-provider relationship. A faster, more automated claims platform can improve operational efficiency, but it can also expose mismatches in coding, billing, and reimbursement expectations that were previously buried in manual workflows. When appeals rise, administrative burden rises with them, and so do the odds of delayed resolution, reserve pressure, and medical-cost noise that obscures the underlying trend in utilization.
Kao said the company has spent several months expanding payment integrity capabilities and adding resources to support clinical best practices in an effort to reduce variation in member outcomes. Those investments appear to have helped in September and into October, but management is still treating the back half of the year cautiously.
The guidance revision reflects that caution.
Kao said the company is assuming the higher third-quarter cost trend will continue to weigh on results through year-end. He framed the outlook as one the company believes it can deliver, even as it works through the operational impact of the claims transition and the associated spike in disputes.
Catastrophic care, skilled nursing, and utilization drift are squeezing results
The pressure points named by management are familiar to anyone following Medicare Advantage economics. Catastrophic care tends to mark a small share of members but a disproportionate share of spend, while skilled nursing can swing quickly when post-acute utilization rises or discharge patterns change. In a business model built on predictable risk adjustment and tight care management, sudden movement in either category can distort quarterly performance.
The company’s third-quarter loss, despite strong year-over-year revenue growth, suggests that cost trend outran reimbursement and operating gains. Through the first nine months of 2026, Alignment still remained profitable, with $39.9 million in profits versus $10.3 million in the same period of 2025. Even so, the pressure in the most recent quarter signals that the year-end run rate may be less favorable than earlier results implied.
For a Medicare Advantage plan, the challenge is not simply paying claims. It is paying them correctly, quickly, and in a way that preserves both provider trust and margin discipline. When any one of those pieces slips, the rest of the system feels it.
Stars ratings fell sharply and one California plan drove the decline
The company is also dealing with a significant setback in Medicare Advantage Star Ratings. Based on federal data, 25% of members are in plans with at least four stars for 2027, down from 100% in 2026. Four stars is the threshold tied to quality bonus payments, so the change has direct financial consequences.
Six of the company’s seven contracts remained above four stars, but a 3.5 score on one remaining plan, a core HMO in California, pulled down the overall result. A single weaker contract can matter a great deal when quality bonus revenue is tied to star performance at the plan level. In that setting, one underperforming product can erode the economics of an otherwise stronger portfolio.
Kao said the team is focused on getting to the root issues in Stars and that the problem is receiving companywide attention. The company has also sued the Centers for Medicare & Medicaid Services over the 2027 calculations, signaling that the ratings dispute is now both an operational and legal issue.
Quality scores now carry a larger financial burden
Star ratings influence more than reputation. They shape bonus payments, affect competitiveness in Medicare Advantage markets, and can alter how aggressively a company can invest in growth, care management, and member acquisition. When a plan loses access to higher-star revenue, the hit can arrive just as medical costs are rising, creating a difficult two-front squeeze.
Alignment’s case shows how closely clinical quality measures and financial outcomes are linked in managed care. A 3.5-star score on one major HMO plan is not just a metrics issue; it changes the economics of the product and raises the stakes for every operational fix the company now needs to make.
Kao said the company will keep working to address the root causes and get the issue fixed. The immediate problem is more concrete: higher costs are already in the run rate, and only a fraction of members now sit in plans that qualify for the four-star threshold that supports quality bonus payments.
The combination leaves Alignment balancing two difficult tasks at once. It must stabilize claims operations and clinical cost trend while also repairing the quality position that helps fund the business. Each of those challenges carries its own operational drag, and both are now pressing on the same year-end financial outlook.